List view / Grid view
9 July 2015 | By Victoria White
A trial of has shown up to 86% of patients with psoriasis receiving guselkumab achieved a PGA score of cleared psoriasis or minimal psoriasis at week 16...
8 July 2015 | By Victoria White
Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria...
8 July 2015 | By Victoria White
Arrowhead Research Corporation has received regulatory permission in the UK and New Zealand to proceed with Part B of its Phase 1 study of ARC-AAT...
8 July 2015 | By Victoria White
Lilly’s NSCLC drug, necitumumab, has raised concerns with the FDA after trial data suggested that the drug might increase the likelihood of fatal clots...
8 July 2015 | By Victoria White
AXON Neuronscience's vaccine intended to be a disease modifying drug for Alzheimer’s disease patients has passed a Phase 1 safety trial...
8 July 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Novartis' Entresto (sacubitril/valsartan) tablets for the treatment of heart failure with reduced ejection fraction.
8 July 2015 | By Victoria White
Genticel has announced that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its Phase 2 clinical trial of GTL001...
8 July 2015 | By Victoria White
Eisai’s Fycompa (perampanel), a once-daily epilepsy treatment that inhibits AMPA receptors, launches in the United Kingdom today...
7 July 2015 | By Victoria White
A new study has found that less than 1% of 11,000 healthy volunteers who participated in 394 Phase I trials for new drugs experienced serious complications...
7 July 2015 | By
Celtaxsys has gained clearance from the US FDA to begin a Phase 2 clinical trial of acebilustat in adult patients with cystic fibrosis (CF) in the US...
7 July 2015 | By Victoria White
The first patients have been enrolled in a Phase 2b clinical trial of Pfizer’s S. aureus vaccine in adults undergoing elective spinal fusion surgery...
7 July 2015 | By Victoria White
Allergan is to acquire exclusive worldwide rights to Merck's CGRP receptor antagonists, which are being developed for the treatment of migraine...
7 July 2015 | By Victoria White
Testing thousands of approved drugs, EPFL scientists have found that an over-the-counter antacid, lansoprazole, may be an effective anti-tuberculosis drug...
7 July 2015 | By Victoria White
A new investigational vaccine designed to protect against West Nile Virus infection is being tested in a Phase 1 clinical trial...
7 July 2015 | By Victoria White
BARDA, a division of the US Department of Health & Human Services, has ordered a bulk supply of Bavarian Nordic’s Imvamune non-replicating smallpox vaccine...
